REGENXBIO Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by REGENXBIO Inc.
RECRUITINGNCT05683379
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Sponsor: REGENXBIO Inc.Enrolling: 2001 location
Duchenne Muscular Dystrophy
RECRUITINGPhase 2 / Phase 3NCT05693142
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RGX-202 is a gene therapy designed to deliver a transgene for a novel microdystrophin that includes functional elements of naturally-occurring dystrophin including the C-Terminal...
Sponsor: REGENXBIO Inc.Enrolling: 6517 locations
Duchenne Muscular Dystrophy